pharma · Chronic Inflammatory Demyelinating Polyneuropathy · Multifocal Motor Neuropathy · DNTH
Dianthus Therapeutics, Inc
Dianthus Therapeutics, Inc. /DE/
Dianthus Therapeutics, Inc clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
New York City, USA HQ
111 Employees
Public company Type
DNTH · NYSE Ticker
Company details
- Status
- Public
- HQ
- New York City, USA
- Employees
- 111
- Programs
- 6
- Drugs
- 12
- Patents
- 2
Dianthus Therapeutics, Inc projects
2 ClinicalTrials.gov programs sponsored by Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Dianthus Therapeutics, Inc have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.